ClinicalTrials.gov record
Active, not recruiting Phase 1 Interventional

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

ClinicalTrials.gov ID: NCT06847854

Public ClinicalTrials.gov record NCT06847854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 1:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I, Multipart, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7497372 Following Intravitreal Administration in Participants With Diabetic Macular Edema (Part 1 Non-Randomized, Open-Label, Multiple Ascending Dose; Part 2 Randomized, Double-Masked)

Study identification

NCT ID
NCT06847854
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Genentech, Inc.
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

  • RO7497372 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2022
Primary completion
Nov 15, 2026
Completion
Jan 11, 2027
Last update posted
Apr 19, 2026

2022 – 2027

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Mesa Arizona 85206
Retinal Consultants of AZ, Ltd Peoria Arizona 85381
Associated Retina Consultants Phoenix Arizona 85020
Arkansas Retina Research Little Rock Arkansas 72205
Global Research Management Glendale California 91204
Retinal Consultants Medical Group Modesto California 95356
Bay Area Retina Associates Walnut Creek California 94598
Florida Eye Associates Melbourne Florida 32901
Medeye Associates Miami Florida 33143
East Florida Eye Institute Stuart Florida 34994
Retina Specialists of Tampa Wesley Chapel Florida 33544
Center for Retina and Macula Disease Winter Haven Florida 33880
Cumberland Valley Retina PC Hagerstown Maryland 21740
Retina Associates of Michigan Grand Blanc Michigan 48439-8301
Foundation for Vision Research Grand Rapids Michigan 49546
Retina Consultants Minnesota Saint Louis Park Minnesota 55416
Mississippi Retina Associates Madison Mississippi 39202
The Retina Institute St Louis Missouri 63128
Sierra Eye Associates Reno Nevada 89502
Ross Eye Institute Buffalo New York 14209-2102
Retina Associates of NY New York New York 10075
Cleveland Clinic Cleveland Ohio 44106
Verum Research LLC Eugene Oregon 97401
EyeHealth Northwest Portland Oregon 97225
Erie Retinal Surgery Erie Pennsylvania 16507
Mid Atlantic Retina Philadelphia Pennsylvania 19107
Carolina Eyecare Physicians Mt. Pleasant South Carolina 29464
Charles Retina Institute Germantown Tennessee 38138
Austin Clinical Research LLC Austin Texas 78750
Brown Retina Institute Schertz Texas 78154
Retina Consultants of Texas The Woodlands Texas 77384
Salt Lake Retina West Jordan Utah 84088
Retina Group of Washington Fairfax Virginia 20815
Emerson Clinical Research Institute Falls Church Virginia 78503
Piedmont Eye Center Lynchburg Virginia 24502
Wagner Kapoor Institute Norfolk Virginia 23502
Spokane Eye Clinical Research Spokane Washington 99204-2509

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06847854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06847854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →